These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31182257)

  • 1. Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?
    Suaifan GARY; Mohammed AAM
    Bioorg Med Chem; 2019 Jul; 27(14):3005-3060. PubMed ID: 31182257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
    Kocsis B; Domokos J; Szabo D
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines.
    Suaifan GARY; Mohammed AAM; Alkhawaja BA
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Trends and Future Directions of Fluoroquinolones.
    Mohammed HHH; Abuo-Rahma GEAA; Abbas SH; Abdelhafez EMN
    Curr Med Chem; 2019; 26(17):3132-3149. PubMed ID: 29446718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline.
    Kocsis B; Gulyás D; Szabó D
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
    Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
    Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluoroquinolones: Non-antibacterial properties].
    Leyva-Ramos S; Hernández-López H
    Rev Esp Quimioter; 2017 Feb; 30(1):1-8. PubMed ID: 27976571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of a Novel Anionic Fluoroquinolone-Delafloxacin.
    Tulkens PM; Van Bambeke F; Zinner SH
    Clin Infect Dis; 2019 Apr; 68(Suppl 3):S213-S222. PubMed ID: 30957164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, molecular docking, and antibacterial evaluation of some novel flouroquinolone derivatives as potent antibacterial agent.
    Patel MM; Patel LJ
    ScientificWorldJournal; 2014; 2014():897187. PubMed ID: 25574496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolones: structure-activity relationships and future predictions.
    Tillotson GS
    J Med Microbiol; 1996 May; 44(5):320-4. PubMed ID: 8636945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent updates of fluoroquinolones as antibacterial agents.
    Ezelarab HAA; Abbas SH; Hassan HA; Abuo-Rahma GEA
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800141. PubMed ID: 30048015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine.
    Purkayastha N; Capone S; Beck AK; Seebach D; Leeds J; Thompson K; Moser HE
    Chem Biodivers; 2015 Feb; 12(2):179-93. PubMed ID: 25676502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delafloxacin for the treatment of respiratory and skin infections.
    Bassetti M; Della Siega P; Pecori D; Scarparo C; Righi E
    Expert Opin Investig Drugs; 2015 Mar; 24(3):433-42. PubMed ID: 25604710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
    Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
    Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
    Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y
    Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
    Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.